These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 37047172)

  • 61. The use of solid lipid nanoparticles for sustained drug release.
    Attama AA; Umeyor CE
    Ther Deliv; 2015; 6(6):669-84. PubMed ID: 26149784
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil.
    Shi F; Zhao JH; Liu Y; Wang Z; Zhang YT; Feng NP
    Int J Nanomedicine; 2012; 7():2033-43. PubMed ID: 22619540
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chitosan-coupled solid lipid nanoparticles: Tuning nanostructure and mucoadhesion.
    Sandri G; Motta S; Bonferoni MC; Brocca P; Rossi S; Ferrari F; Rondelli V; Cantù L; Caramella C; Del Favero E
    Eur J Pharm Biopharm; 2017 Jan; 110():13-18. PubMed ID: 27989765
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Solid Lipid Nanoparticles: Review of the Current Research on Encapsulation and Delivery Systems for Active and Antioxidant Compounds.
    Subroto E; Andoyo R; Indiarto R
    Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978881
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers.
    You P; Yuan R; Chen C
    Drug Des Devel Ther; 2017; 11():2743-2752. PubMed ID: 29075099
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications.
    Nunes S; Madureira AR; Campos D; Sarmento B; Gomes AM; Pintado M; Reis F
    Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1863-1873. PubMed ID: 26192708
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Carbohydrate anchored lipid nanoparticles.
    Kakade P; Chatterjee A; Pandya A; Disouza J; Patravale V
    Int J Pharm; 2022 Apr; 618():121681. PubMed ID: 35307469
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Protective effect of l-carnitine-loaded solid lipid nanoparticles against H
    Eskandani M; Eskandani M; Vandghanooni S; Navidshad B; Aghjehgheshlagh FM; Nobakht A
    Colloids Surf B Biointerfaces; 2022 Apr; 212():112365. PubMed ID: 35124408
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.
    Das S; Chaudhury A
    AAPS PharmSciTech; 2011 Mar; 12(1):62-76. PubMed ID: 21174180
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Receptor-Mediated Targeting in Breast Cancer through Solid Lipid Nanoparticles and Its Mechanism.
    Malik Z; Parveen R; Abass S; Irfan Dar M; Husain SA; Ahmad S
    Curr Drug Metab; 2022; 23(10):800-817. PubMed ID: 35430962
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment.
    Oliveira MS; Goulart GCA; Ferreira LAM; Carneiro G
    Expert Opin Drug Deliv; 2017 Aug; 14(8):983-995. PubMed ID: 27892713
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preparation, in vitro and in vivo Evaluation of Thermosensitive in situ Gel Loaded with Ibuprofen-Solid Lipid Nanoparticles for Rectal Delivery.
    Huang CH; Hu PY; Wu QY; Xia MY; Zhang WL; Lei ZQ; Li DX; Zhang GS; Feng JF
    Drug Des Devel Ther; 2022; 16():1407-1431. PubMed ID: 35586185
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Advancements and prospects of lipid-based nanoparticles: dual frontiers in cancer treatment and vaccine development.
    Shaw I; Boafo GF; Ali YS; Liu Y; Mlambo R; Tan S; Chen C
    J Microencapsul; 2024 May; 41(3):226-254. PubMed ID: 38560994
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Methods for preparation of nanostructured lipid carriers.
    Gomaa E; Fathi HA; Eissa NG; Elsabahy M
    Methods; 2022 Mar; 199():3-8. PubMed ID: 33992771
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies.
    Rehman M; Ihsan A; Madni A; Bajwa SZ; Shi D; Webster TJ; Khan WS
    Int J Nanomedicine; 2017; 12():8325-8336. PubMed ID: 29200845
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment.
    Graván P; Aguilera-Garrido A; Marchal JA; Navarro-Marchal SA; Galisteo-González F
    Adv Colloid Interface Sci; 2023 Apr; 314():102871. PubMed ID: 36958181
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers.
    Lu L; Kang S; Sun C; Sun C; Guo Z; Li J; Zhang T; Luo X; Liu B
    Curr Top Med Chem; 2020; 20(27):2427-2441. PubMed ID: 32842941
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lipid-based Nanoparticulate Drug Delivery.
    Gandhi S; Shastri DH
    Pharm Nanotechnol; 2024 Jan; ():. PubMed ID: 38185889
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Improved Method for Solid Lipid Nanoparticle Preparation Based on Hot Microemulsions: Preparation, Characterization, Cytotoxicity, and Hemocompatibility Evaluation.
    Kotmakçı M; Akbaba H; Erel G; Ertan G; Kantarcı G
    AAPS PharmSciTech; 2017 May; 18(4):1355-1365. PubMed ID: 27502405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.